Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Dyment

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
A genome scan in a single pedigree with a high prevalence of multiple sclerosisD A Dyment, M Z Cader, B M Herrera, et al.
Journal of Neurology|April 11, 2007
The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcomeG C DeLuca, S V Ramagopalan, M Z Cader, et al.
Genes and Immunity|June 2, 2006
Follow-up investigation of 12 proposed linkage regions in multiple sclerosisB M Herrera, M Z Cader, D A Dyment, et al.
Journal of Neuroimmunology|March 23, 2007
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosisS V Ramagopalan, G C Deluca, K M Morrison, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Multiple sclerosis susceptibility and the X chromosomeB M Herrera, M Z Cader, D A Dyment, et al.
Clinical Genetics|June 1, 2018
A ZPR1 mutation is associated with a novel syndrome of growth restriction, distinct craniofacial features, alopecia, and hypoplastic kidneysY A Ito, A C Smith, K D Kernohan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locusG C DeLuca, S V Ramagopalan, B M Herrera, et al.
Clinical Genetics|January 16, 2015
LIMS2 mutations are associated with a novel muscular dystrophy, severe cardiomyopathy and triangular tonguesJodi Warman Chardon, A C Smith, J Woulfe, et al.
Clinical Genetics|October 30, 2013
Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsyD A Dyment, E Sell, M R Vanstone, et al.
Clinical Genetics|July 22, 2014
Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective studyD A Dyment, M Tétreault, C L Beaulieu, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|June 7, 2007
A genome scan in a single pedigree with a high prevalence of multiple sclerosisD A Dyment, M Z Cader, B M Herrera, et al.
Journal of Neurology|April 11, 2007
The role of hereditary spastic paraplegia related genes in multiple sclerosis. A study of disease susceptibility and clinical outcomeG C DeLuca, S V Ramagopalan, M Z Cader, et al.
Genes and Immunity|June 2, 2006
Follow-up investigation of 12 proposed linkage regions in multiple sclerosisB M Herrera, M Z Cader, D A Dyment, et al.
Journal of Neuroimmunology|March 23, 2007
No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosisS V Ramagopalan, G C Deluca, K M Morrison, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 21, 2007
Multiple sclerosis susceptibility and the X chromosomeB M Herrera, M Z Cader, D A Dyment, et al.
Clinical Genetics|June 1, 2018
A ZPR1 mutation is associated with a novel syndrome of growth restriction, distinct craniofacial features, alopecia, and hypoplastic kidneysY A Ito, A C Smith, K D Kernohan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locusG C DeLuca, S V Ramagopalan, B M Herrera, et al.
Clinical Genetics|January 16, 2015
LIMS2 mutations are associated with a novel muscular dystrophy, severe cardiomyopathy and triangular tonguesJodi Warman Chardon, A C Smith, J Woulfe, et al.
Clinical Genetics|October 30, 2013
Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsyD A Dyment, E Sell, M R Vanstone, et al.
Clinical Genetics|July 22, 2014
Whole-exome sequencing broadens the phenotypic spectrum of rare pediatric epilepsy: a retrospective studyD A Dyment, M Tétreault, C L Beaulieu, et al.
Pageof 5